Paper34845679
In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours.
Akanda M and 2 others. Drug Deliv Transl Res, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours. Papers, record 34845679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34845679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanostructures | Major topic |
| Prostatic Neoplasms | Major topic |
| Male | |
| Mice | |
| Humans | |
| Animals | |
| Drug Carriers | |
| Mice, Nude | |
| Lipids | |
| Particle Size |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33782898 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. | Drug Deliv Transl Res | 2022 | https://conductscience.org/library/papers/33782898 | PubMed |
| 2 | 25367836 | Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. | Drug Deliv | 2016 | https://conductscience.org/library/papers/25367836 | PubMed |
| 3 | 12753761 | Particle size of liposomes influences dermal delivery of substances into skin. | Int J Pharm | 2003 | https://conductscience.org/library/papers/12753761 | PubMed |
| 4 | 20553984 | The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. | Biomaterials | 2010 | https://conductscience.org/library/papers/20553984 | PubMed |
| 5 | 31773421 | Nanotechnology to improve the Alzheimer's disease therapy with natural compounds. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/31773421 | PubMed |
| 6 | 21592751 | Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion. | Colloids Surf B Biointerfaces | 2011 | https://conductscience.org/library/papers/21592751 | PubMed |
| 7 | 32924677 | Fabrication, optimisation and in vitro evaluation of docetaxel and curcumin Co-loaded nanostructured lipid carriers for improved antitumor activity against non-small cell lung carcinoma. | J Microencapsul | 2020 | https://conductscience.org/library/papers/32924677 | PubMed |
| 8 | 17543416 | Solid lipid nanoparticles as a drug delivery system for peptides and proteins. | Adv Drug Deliv Rev | 2007 | https://conductscience.org/library/papers/17543416 | PubMed |
| 9 | 16188405 | Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. | Int J Pharm | 2005 | https://conductscience.org/library/papers/16188405 | PubMed |
| 10 | 3042244 | Clinical pharmacokinetics of doxorubicin. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3042244 | PubMed |
| 11 | 20688493 | Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. | Colloids Surf B Biointerfaces | 2010 | https://conductscience.org/library/papers/20688493 | PubMed |
| 12 | 11967955 | Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. | Prostate | 2002 | https://conductscience.org/library/papers/11967955 | PubMed |
| 13 | 33895936 | Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations. | Drug Deliv Transl Res | 2022 | https://conductscience.org/library/papers/33895936 | PubMed |
| 14 | 3139287 | Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. | Cancer Res | 1988 | https://conductscience.org/library/papers/3139287 | PubMed |
| 15 | 26162977 | A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. | Colloids Surf B Biointerfaces | 2015 | https://conductscience.org/library/papers/26162977 | PubMed |
| 16 | 22609787 | Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. | Molecules | 2012 | https://conductscience.org/library/papers/22609787 | PubMed |
| 17 | 23116308 | Recent progress in studying curcumin and its nano-preparations for cancer therapy. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23116308 | PubMed |
| 18 | 20938993 | Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. | Mol Nutr Food Res | 2011 | https://conductscience.org/library/papers/20938993 | PubMed |
| 19 | 31942699 | Thermo-reversible in situ forming implant with nanostructured lipid carriers (NLC) as a delivery system for the administration of estradiol valerate. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/31942699 | PubMed |
| 20 | 31060404 | Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity. | J Liposome Res | 2020 | https://conductscience.org/library/papers/31060404 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42076126 | BSA-Based Nanoparticles for Dual Loading of Pazopanib and Enzalutamide: Formulation Optimization and In Vitro Evaluation in Breast Cancer Cells. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076126 | PubMed |
| 41908436 | Chemosensitizer Effects of Coencapsulation of Curcumin and Cabazitaxel in Nanostructured Lipid Carriers in Glioblastoma Cells. | ACS Omega | 2026 | https://conductscience.org/library/papers/41908436 | PubMed |
| 41661421 | Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailability. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/41661421 | PubMed |
| 40370243 | Advances and Future Prospects of Lipid-Based Nanocarriers in Targeted Cancer Therapy: A Comprehensive Review. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/40370243 | PubMed |
| 39738884 | Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studies. | Drug Deliv Transl Res | 2025 | https://conductscience.org/library/papers/39738884 | PubMed |
| 37768530 | QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/37768530 | PubMed |
| 37630208 | Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine. | Molecules | 2023 | https://conductscience.org/library/papers/37630208 | PubMed |
| 37514275 | From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/37514275 | PubMed |
| 37157192 | Recent Advances in Nanocarrier-based Approaches to Atopic Dermatitis and Emerging Trends in Drug Development and Design. | Curr Drug Deliv | 2024 | https://conductscience.org/library/papers/37157192 | PubMed |
| 36986748 | Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986748 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34845679
GET https://conductscience.org/api/papers/v1/34845679/references?page=2